← Back to search

Roivant Sciences Ltd

ROIV · NASDAQ

Pharmaceutical Preparation Manufacturing

Roivant develops transformative medicines faster by building technologies and developing talent in creative ways, leveraging the Roivant platform to launch "Vants" - nimble and focused biopharmaceutical and health technology companies

ESG Scores

Overall ESG
4.8
Environmental
4.1
Social
2.1
Governance
6.6

Gender Diversity

Female Directors0.25%
CEO GenderMale

Market Data

Price$29.53+0.83 (+2.89%)
Market Cap$21.24B
P/E Ratio
EPS$—
52W High$32.79
52W Low$10.71
Beta1.14